Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06977178 · ClinicalTrials.gov registry record · NA

Adverse Adolescent Pathways to Substance Use

A NA study of Anxiety and Substance Use, sponsored by University of North Carolina, Chapel Hill.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT06977178 is a NA study of Anxiety and Substance Use that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 180 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06977178, a NA study of Anxiety and Substance Use, is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

Purpose: This 5-year R01 study will elucidate the role of maturational change across adolescence in neural connectivity and physiological stress responses in the relationship between anxiety and adverse pathways to substance use (APSU). Participants: Children (N=200) aged 12-14 with symptoms of anxiety and their legal caregiver will be recruited from clinical and community sources. Procedures: Youth participants will complete several questionnaires and interviews, undergo neuroimaging while performing cognitive tasks, and have their heart rate and skin conductance monitored during a mildly stressful task. Caregivers will complete several questionnaires.

Interventions

  • BEHAVIORAL Trier Social Stress Test

Study Locations (1)

North Carolina

  • The University of North Carolina at Chapel Hill School of Medicine - Chapel Hill

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2024-02-20
Est. Completion 2030-06-30
Phase NA

What the Registry Record Tells You About NCT06977178

The ClinicalTrials.gov registry entry for NCT06977178 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (59% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 1 intervention - of which Trier Social Stress Test is the first listed.

NCT06977178 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06977178 about?

NCT06977178 is a clinical study titled "Adverse Adolescent Pathways to Substance Use". Purpose: This 5-year R01 study will elucidate the role of maturational change across adolescence in neural connectivity and physiological stress responses in the relationship between anxiety and adverse pathways to substance use (APSU). Participants: Children (N=200) aged 12-14 with symptoms of anxi...

What is the current status of trial NCT06977178?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2024-02-20. Estimated completion is 2030-06-30.

What conditions does trial NCT06977178 study?

This clinical trial studies the following conditions: Anxiety, Substance Use, Adolescent Development.

What interventions are being tested in trial NCT06977178?

The interventions under investigation include: Trier Social Stress Test (BEHAVIORAL).

Who is sponsoring clinical trial NCT06977178?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06977178 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.